JD HEALTH
06618
TRIP.COM-S
09961
ALI HEALTH
00241
BABA-W
09988
BOSS ZHIPIN-W
02076
(FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -9.28%21.92B | 4.49%12.69B | 17.62%24.16B | 25.21%12.14B | 27.88%20.54B | 20.09%9.7B | 30.44%16.06B | 74.67%8.07B | 35.40%12.32B | 15.66%4.62B |
Operating income | -9.28%21.92B | 4.49%12.69B | 17.62%24.16B | 25.21%12.14B | 27.88%20.54B | 20.09%9.7B | 30.44%16.06B | 74.67%8.07B | 35.40%12.32B | 15.66%4.62B |
Cost of sales | -4.24%-18.45B | 1.99%-9.28B | -23.02%-17.7B | -40.98%-9.47B | -59.45%-14.39B | -86.31%-6.72B | -57.39%-9.02B | -48.11%-3.61B | -10.56%-5.73B | -0.38%-2.43B |
Operating expenses | -4.24%-18.45B | 1.99%-9.28B | -23.02%-17.7B | -40.98%-9.47B | -59.45%-14.39B | -86.31%-6.72B | -57.39%-9.02B | -48.11%-3.61B | -10.56%-5.73B | -0.38%-2.43B |
Gross profit | -46.29%3.47B | 27.45%3.41B | 5.00%6.47B | -10.34%2.67B | -12.55%6.16B | -33.32%2.98B | 6.97%7.04B | 104.21%4.47B | 68.31%6.58B | 39.23%2.19B |
Selling expenses | -31.07%-126.96M | 2.80%-55.91M | -6.08%-96.87M | -447.69%-57.52M | -324.45%-91.31M | 95.80%-10.5M | 93.21%-21.51M | -83.78%-250.24M | -12.46%-316.61M | -8.25%-136.16M |
Administrative expenses | 6.61%-1.02B | -5.11%-594.23M | -11.47%-1.09B | -30.89%-565.33M | -37.78%-979.18M | -21.28%-431.91M | -29.64%-710.7M | -71.06%-356.13M | -28.34%-548.22M | 5.33%-208.19M |
Impairment and provision | -72.00%-15.56M | -69.34%-20.68M | 83.13%-9.05M | ---12.21M | -1,670.91%-53.64M | ---- | 39.77%-3.03M | ---- | 65.15%-5.03M | ---- |
-Other impairment is provision | -72.00%-15.56M | -69.34%-20.68M | 83.13%-9.05M | ---12.21M | -1,670.91%-53.64M | ---- | 39.77%-3.03M | ---- | 65.15%-5.03M | ---- |
Special items of operating profit | -87.95%15.45M | 9.52%131.5M | -54.76%128.17M | 0.45%120.06M | 36.84%283.32M | -9.72%119.53M | 48.46%207.05M | 90.92%132.4M | 11.43%139.46M | 6.53%69.35M |
Operating profit | -56.89%2.33B | 32.88%2.87B | 1.49%5.4B | -18.83%2.16B | -18.37%5.32B | -33.49%2.66B | 11.30%6.51B | 108.79%4B | 76.64%5.85B | 48.19%1.91B |
Financing income | -25.07%23.28M | 26.53%19.9M | 0.65%31.07M | -76.56%15.73M | -80.30%30.87M | -5.92%67.1M | 158.78%156.65M | 224.96%71.32M | 23.31%60.53M | 113.98%21.95M |
Financing cost | -23.92%-432.11M | -39.22%-239.78M | -75.76%-348.7M | -105.60%-172.23M | -40.94%-198.39M | -24.81%-83.77M | 26.28%-140.77M | 42.38%-67.12M | 37.08%-190.95M | 25.35%-116.48M |
Share of profits of associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -284.34%-153K | 96.55%-203K | 188.30%83K |
Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.67%18.76M | -9.02%35.82M | 27.67%18.63M |
Special items of earning before tax | -31.79%17.41M | -14.90%14.76M | -17.15%25.53M | 6.65%17.34M | -19.00%30.81M | --16.26M | --38.04M | ---- | ---- | ---- |
Earning before tax | -62.09%1.94B | 31.88%2.66B | -1.47%5.1B | -24.05%2.02B | -21.12%5.18B | -33.87%2.66B | 14.07%6.57B | 118.65%4.02B | 86.20%5.76B | 58.42%1.84B |
Tax | 33.99%-526.23M | -51.42%-506.51M | 4.55%-797.17M | 20.40%-334.5M | 15.40%-835.21M | 31.46%-420.22M | -34.27%-987.21M | -172.19%-613.12M | -150.04%-735.27M | -146.08%-225.26M |
After-tax profit from continuing operations | -67.29%1.41B | 28.00%2.16B | -0.88%4.31B | -24.74%1.68B | -22.13%4.35B | -34.31%2.24B | 11.11%5.58B | 111.17%3.41B | 79.49%5.02B | 50.91%1.61B |
Earning after tax | -67.29%1.41B | 28.00%2.16B | -0.88%4.31B | -24.74%1.68B | -22.13%4.35B | -34.31%2.24B | 11.11%5.58B | 111.17%3.41B | 79.49%5.02B | 50.91%1.61B |
Minority profit | -13.78%400.84M | -34.09%192.55M | -11.55%464.92M | -12.11%292.15M | -19.97%525.62M | -0.15%332.42M | 42.07%656.76M | 61.50%332.93M | 20.97%462.27M | 77.93%206.15M |
Profit attributable to shareholders | -73.76%1.01B | 41.03%1.96B | 0.59%3.84B | -26.94%1.39B | -22.42%3.82B | -38.01%1.9B | 7.97%4.92B | 118.45%3.07B | 88.74%4.56B | 47.63%1.41B |
Basic earnings per share | -73.89%0.1127 | 40.95%0.2203 | 0.51%0.4317 | -27.03%0.1563 | -22.82%0.4295 | -38.57%0.2142 | 0.45%0.5565 | 100.52%0.3487 | 82.96%0.554 | 44.08%0.1739 |
Diluted earnings per share | -73.89%0.1127 | 40.95%0.2203 | 0.68%0.4316 | -26.96%0.1563 | -22.84%0.4287 | -38.52%0.214 | 0.43%0.5556 | 100.29%0.3481 | 82.76%0.5532 | 43.99%0.1738 |
Currency Unit | CNY | HKD | CNY | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | -- | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.